0001375151-19-000007.txt : 20190214 0001375151-19-000007.hdr.sgml : 20190214 20190214204100 ACCESSION NUMBER: 0001375151-19-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190212 FILED AS OF DATE: 20190214 DATE AS OF CHANGE: 20190214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARNER CAM L CENTRAL INDEX KEY: 0001024007 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 19609519 MAIL ADDRESS: STREET 1: PO BOX 675866 CITY: RANCHO SANTE FE STATE: CA ZIP: 92067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_155019484594974.xml FORM 4 X0306 4 2019-02-12 0 0001375151 ZOGENIX, INC. ZGNX 0001024007 GARNER CAM L C/O ZOGENIX, INC. 5858 HORTON STREET, SUITE 455 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2019-02-12 4 M 0 218 32 A 218 D Common Stock 2019-02-12 4 M 0 1562 30.96 A 1780 D Common Stock 2019-02-12 4 M 0 6250 15.04 A 8030 D Common Stock 2019-02-12 4 M 0 4375 14.88 A 12405 D Common Stock 2019-02-12 4 S 0 12405 46.8478 D 0 D Common Stock 40843 I By Garner Investments, LLC Stock Option (Right to Buy) 32.0 2019-02-12 4 M 0 218 0 D 2020-05-29 Common Stock 218.0 0 D Stock Option (Right to Buy) 30.96 2019-02-12 4 M 0 1562 0 D 2021-05-23 Common Stock 1562.0 0 D Stock Option (Right to Buy) 15.04 2019-02-12 4 M 0 6250 0 D 2022-04-26 Common Stock 6250.0 0 D Stock Option (Right to Buy) 14.88 2019-02-12 4 M 0 4375 0 D 2022-06-05 Common Stock 4375.0 0 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $46.31 to $47.19, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Reporting Person is the managing member of Garner Investments, LLC. The Option was granted on May 30, 2010 and vests in a series of twelve (12) successive, equal monthly installments beginning on the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. The Option was granted on May 24, 2011 and vests in a series of twelve (12) successive, equal monthly installments beginning on the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. The Option was granted on April 27, 2012 and vests in a series of thirty-six (36) successive, equal monthly installments beginning on the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. The Option was granted on June 6, 2012 and vests in a series of twelve (12) successive, equal monthly installments beginning on the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. /s/ Thomas Doyle, Attorney-in-fact for Cam L. Garner 2019-02-14